| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:28414157 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:28414157 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:19788401; PMID:27048571; PMID:28414157; PMID:28414157; PMID:9794803 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:27048571; PMID:27048571; PMID:28414157; PMID:28414157 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:27048571; PMID:27048571; PMID:28414157; PMID:28414157 |
| GO:0006094 | Gluconeogenesis | Decreases phenotype | PMID:8665939 |
| GO:0006260 | Dna replication | Increases phenotype | PMID:25145657; PMID:32435917 |
| GO:0006306 | Dna methylation | Increases phenotype | PMID:24157574; PMID:33549593 |
| GO:0006309 | Apoptotic dna fragmentation | Decreases phenotype | PMID:8640813 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:35358606 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:24493665; PMID:27048571; PMID:27048571; PMID:28414157; PMID:28414157 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:24021950; PMID:25745819; PMID:35597399; PMID:6135573 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:28414157 |
| GO:0006811 | Monoatomic ion transport | Increases phenotype | PMID:2167745 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10449034; PMID:17963809; PMID:24090815; PMID:26865186; PMID:8640813; PMID:9230198 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:27048571; PMID:29777724; PMID:30842367 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:10817630 |
| GO:0007268 | Chemical synaptic transmission | Affects phenotype | PMID:12694808 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:28495587 |
| GO:0008219 | Cell death | Increases phenotype | PMID:19437554; PMID:24493665 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:17963809; PMID:33398415; PMID:35881160; PMID:19437554; PMID:23626729; PMID:24025784; PMID:24090815; PMID:24157574; PMID:28414157; PMID:28495587; PMID:33398415; PMID:34813904; PMID:39909212 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:24449422; PMID:29244179 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:32949729 |
| GO:0008361 | Regulation of cell size | Increases phenotype | PMID:3426617 |
| GO:0009825 | Multidimensional cell growth | Increases phenotype | PMID:32320717 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:1933335; PMID:9215992 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:27048571; PMID:27048571; PMID:28414157; PMID:28414157; PMID:35113675; PMID:35358606 |
| GO:0016401 | Palmitoyl-coa oxidase activity | Decreases phenotype | PMID:32320717 |
| GO:0016712 | Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | Increases phenotype | PMID:29425889; PMID:32320717 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:27048571 |
| GO:0018411 | Protein glucuronidation | Increases phenotype | PMID:36549901 |
| GO:0018685 | Alkane 1-monooxygenase activity | Decreases phenotype | PMID:32320717 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:35113675 |
| GO:0030199 | Collagen fibril organization | Affects phenotype | PMID:34796763 |
| GO:0030307 | Positive regulation of cell growth | Increases phenotype | PMID:31465819 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:30842367 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:27427493 |
| GO:0032770 | Positive regulation of monooxygenase activity | Increases phenotype | PMID:32320717 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:6547179 |
| GO:0042168 | Heme metabolic process | Affects phenotype | PMID:35113675 |
| GO:0042178 | Xenobiotic catabolic process | Increases phenotype | PMID:7483660; PMID:7483660; PMID:9817083; PMID:9929512; PMID:9817083; PMID:9929512 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:23439660; PMID:31465819 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:39909212 |
| GO:0043971 | Histone h3-k18 acetylation | Increases phenotype | PMID:28495587 |
| GO:0046034 | Atp metabolic process | Increases phenotype | PMID:32320717; PMID:32949729 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:35113675 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:10817630; PMID:8638846 |
| GO:0046620 | Regulation of organ growth | Increases phenotype | PMID:9121950 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:29548889; PMID:29548889; PMID:31465819 |
| GO:0047962 | Glycine n-benzoyltransferase activity | Increases phenotype | PMID:2818615 |
| GO:0050649 | Testosterone 6-beta-hydroxylase activity | Increases phenotype | PMID:32320717 |
| GO:0051354 | Negative regulation of oxidoreductase activity | Affects phenotype | PMID:32320717 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:24493665 |
| GO:0060013 | Righting reflex | Decreases phenotype | PMID:29944862; PMID:29944862; PMID:37115471; PMID:37115471 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:31270302 |
| GO:0070633 | Transepithelial transport | Decreases phenotype | PMID:18063342 |
| GO:0070989 | Oxidative demethylation | Increases phenotype | PMID:28218408 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:24025784; PMID:24486436 |
| GO:0071897 | Dna biosynthetic process | Increases phenotype | PMID:27530964; PMID:29142176 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:23665940; PMID:23665940; PMID:24025784; PMID:24025784; PMID:24493665; PMID:35358606 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:28495587 |
| GO:0090592 | Dna synthesis involved in dna replication | Increases phenotype | PMID:28520973; PMID:31465819; PMID:29425889; PMID:29425889; PMID:32027962; PMID:29548889; PMID:31465819; PMID:32027962; PMID:32320717 |
| GO:0098657 | Import into cell | Affects phenotype | PMID:36216988 |
| GO:0098781 | Ncrna transcription | Increases phenotype | PMID:28541575 |
| GO:1900064 | Positive regulation of peroxisome organization | Increases phenotype | PMID:25786523 |
| GO:1901113 | Erythromycin metabolic process | Increases phenotype | PMID:16844145 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:30633929 |
| GO:2000573 | Positive regulation of dna biosynthetic process | Increases phenotype | PMID:28218408 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:19760798 |
| GO:2001169 | Regulation of atp biosynthetic process | Affects phenotype | PMID:32027962 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.